Literature DB >> 14984455

Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus.

W Otter1, S Kleybrink, W Doering, E Standl, O Schnell.   

Abstract

AIMS: To assess hospital mortality and morbidity in diabetic and non-diabetic patients with acute myocardial infarction and to compare the results between the two groups.
METHODS: All patients admitted in 1999 to the intensive care unit of the Schwabing City Hospital with diagnosis of acute myocardial infarction were assessed for hospital mortality and co-morbidity.
RESULTS: Three hundred and thirty patients with acute myocardial infarction were admitted. Of those, 126 (38%) were diabetic and 204 (62%) were non-diabetic patients. Mortality within 24 h after admission was 13.5% in diabetic patients and 5.4% in non-diabetic patients (P<0.01). Mortality during entire hospitalization was higher in diabetic than in non-diabetic patients (29.4% vs. 16.2%; P=0.004). Diabetic patients were resuscitated more frequently than non-diabetic patients (24% vs. 11%, P<0.01). In diabetic patients, heart rate at admission was increased (91 +/- 27 vs. 82 +/- 23/min; P<0.01) and presence of angina pectoris was reported less frequently (59% (n=72) vs. 82% (n=167); P<0.001). Preceding myocardial infarction, microalbuminuria, peripheral artery disease and arterial hypertension were more frequent in diabetic than in non-diabetic patients. Diabetic patients demonstrated higher C-reactive protein (CRP) levels than non-diabetic patients (91.4 +/- 78.2 mg/l vs. 45.2 +/- 62.4 mg/l; P<0.001).
CONCLUSIONS: In diabetic patients with acute myocardial infarction, early hospital mortality is increased and signs of cardiac autonomic dysfunction and microangiopathy are detected more frequently than in non-diabetic patients. The need for advanced treatment strategies early in the course of diabetic patients with myocardial infarction is emphasized.

Entities:  

Mesh:

Year:  2004        PMID: 14984455     DOI: 10.1111/j.1464-5491.2004.01114.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

1.  Blood glucose control and coronary heart disease.

Authors:  Cristina Bianchi; Giuseppe Penno; Roberto Miccoli; Stefano Del Prato
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

2.  [Glucose control in cardiac disease].

Authors:  O Schnell
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

3.  Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

Authors:  R Doerr; U Hoffmann; W Otter; L Heinemann; W Hunger-Battefeld; B Kulzer; A Klinge; V Lodwig; I Amann-Zalan; D Sturm; D Tschoepe; S G Spitzer; J Stumpf; T Lohmann; O Schnell
Journal:  Diabetologia       Date:  2011-07-20       Impact factor: 10.122

4.  Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission.

Authors:  Anna Norhammar; Johan Lindbäck; Lars Rydén; Lars Wallentin; Ulf Stenestrand
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

5.  Anemia and hypertension are risk factors for both renal prognosis and survival in patients with diabetes mellitus.

Authors:  Yoshie Sasatomi; Hidetoshi Kaneoka; Yasuhiro Abe; Atunori Ishimura; Satoru Ogahara; Toshiaki Murata; Noriko Uesugi; Shigeo Takebayashi; Hiroshi Iwasaki; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2009-05-19       Impact factor: 2.801

6.  Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?

Authors:  Vasilios G Athyros; Thomas D Gossios; Konstantinos Tziomalos; Matilda Florentin; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

7.  Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study.

Authors:  Daniel I Bromage; Tom R Godec; Mar Pujades-Rodriguez; Arturo Gonzalez-Izquierdo; S Denaxas; Harry Hemingway; Derek M Yellon
Journal:  Cardiovasc Diabetol       Date:  2019-12-09       Impact factor: 8.949

Review 8.  The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice.

Authors:  Oliver Schnell; Wolfgang Otter; Eberhard Standl
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: role of type 2 diabetes mellitus.

Authors:  Zhang Han; Yang Yan-min; Zhu Jun; Liu Li-sheng; Tan Hui-qiong; Liu Yao
Journal:  BMC Cardiovasc Disord       Date:  2012-11-15       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.